This is Fantastic: Shirley D’Sa on Transfusion-Free Christmas Milestone for π-Thalassaemia Patient at UCLH
Shirley D’Sa, Professor of Haematology at United KingdomUnited Kingdom, reposted from University College London Hospitals NHS Foundation Trust on LinkedIn:
”This is fantastic!!!”
Quoting University College London Hospitals NHS Foundation Trust‘s post:
”A UCLH patient with beta thalassaemia has spent her first ever Christmas without needing to plan her life around blood transfusions after a gene-editing therapy has left her able to produce her own red blood cells.
Kavita Mehta (pictured) has transfusion-dependent beta thalassaemia (TDT), which means she does not produce enough haemoglobin, the protein in red blood cells that carries oxygen round the body.
This means she usually has to have a blood transfusion every three weeks.
Kavita said: βA life of regular blood transfusions is all I know.
I cannot believe that doctors have already seen signs that I am now able to produce my own red blood cells.
I canβt tell you what this means to me, and to my family who have had to watch me go through this and care for me.
And more than anything, I am thrilled that this drug is available on the NHS and may help patients who are much younger than me live a life independent of transfusionsβ.
UCLH haematology consultant Ben Carpenter, who has been treating Kavita, said: βWe are pleased with the way things are going for our first patient.
She had a challenging time in hospital but is now feeling much better.
It has been more than two weeks since Kavita’s last red cell transfusion, and her levels are continuing to rise independently.
We are now seeing normal red blood cells being produced by her own bone marrow for the first time since she was born.β
Find out more.”
Stay updated with Hemostasis Today.
-
Apr 8, 2026, 18:14Simon Fletcher: See The Unique Challenges PwH Face During Their Gene Therapy Journey
-
Apr 8, 2026, 17:56Hisam Siddiqi: Understanding Bone Marrow Trephine Morphology in MPNs
-
Apr 8, 2026, 17:46Mohamed Reda: Why Some Veins Decide to Take a ‘Detour’?
-
Apr 8, 2026, 17:39Managing Acquired Von Willebrand Syndrome in a Swine Polytrauma Model During ECLS – JTH
-
Apr 8, 2026, 17:04Heghine Khachatryan: Marfan vs LDS – Not All Aortopathies Are the Same
-
Apr 8, 2026, 17:00Frits Rosendaal Receives ISTH Grant Medal for Lifetime Contributions to Thrombosis and Hemostasis Field
-
Apr 8, 2026, 16:25Xiaoying Chen: Teleneurological Ward As A Practical Way to Support High-Quality Stroke Care Beyond Major Centres
-
Apr 8, 2026, 16:24Ney Carter Borges: Endocrine Drivers of Resistant Hypertension – Insights from the MOMENTUM Trial at ACC 26
-
Apr 8, 2026, 16:21Jonathan Gelber: Exploring Papaya Extract as an Option to Elevate Platelet Numbers Before PRP